These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27386551)

  • 1. Tumor-homing peptides as tools for targeted delivery of payloads to the placenta.
    King A; Ndifon C; Lui S; Widdows K; Kotamraju VR; Agemy L; Teesalu T; Glazier JD; Cellesi F; Tirelli N; Aplin JD; Ruoslahti E; Harris LK
    Sci Adv; 2016 May; 2(5):e1600349. PubMed ID: 27386551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy.
    Cureton N; Korotkova I; Baker B; Greenwood S; Wareing M; Kotamraju VR; Teesalu T; Cellesi F; Tirelli N; Ruoslahti E; Aplin JD; Harris LK
    Theranostics; 2017; 7(15):3715-3731. PubMed ID: 29109771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice.
    Zhang B; Tan L; Yu Y; Wang B; Chen Z; Han J; Li M; Chen J; Xiao T; Ambati BK; Cai L; Yang Q; Nayak NR; Zhang J; Fan X
    Theranostics; 2018; 8(10):2765-2781. PubMed ID: 29774074
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel Technologies for Target Delivery of Therapeutics to the Placenta during Pregnancy: A Review.
    Pepe GJ; Albrecht ED
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-Functionalized Nanoparticles as Efficient Tools in Targeted Therapy of Pregnancy Complications.
    Zhang B; Liang R; Zheng M; Cai L; Fan X
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental Homing Peptide-microRNA Inhibitor Conjugates for Targeted Enhancement of Intrinsic Placental Growth Signaling.
    Beards F; Jones LE; Charnock J; Forbes K; Harris LK
    Theranostics; 2017; 7(11):2940-2955. PubMed ID: 28824727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal insulin-like growth factors-I and -II act via different pathways to promote fetal growth.
    Sferruzzi-Perri AN; Owens JA; Pringle KG; Robinson JS; Roberts CT
    Endocrinology; 2006 Jul; 147(7):3344-55. PubMed ID: 16556757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods.
    Zhang B; Chen Z; Han J; Li M; Nayak NR; Fan X
    J Vis Exp; 2018 Sep; (139):. PubMed ID: 30247484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal insulin-like growth factor-II promotes placental functional development via the type 2 IGF receptor in the guinea pig.
    Sferruzzi-Perri AN; Owens JA; Standen P; Roberts CT
    Placenta; 2008 Apr; 29(4):347-55. PubMed ID: 18339421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction.
    Renshall LJ; Beards F; Evangelinos A; Greenwood SL; Brownbill P; Stevens A; Sibley CP; Aplin JD; Johnstone ED; Teesalu T; Harris LK
    Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient siRNA transfer to knockdown a placenta specific lncRNA using RGD-modified nano-liposome: A new preeclampsia-like mouse model.
    Yu Q; Qiu Y; Wang X; Tang J; Liu Y; Mei L; Li M; Yang M; Tang L; Gao H; Zhang Z; Xu W; He Q
    Int J Pharm; 2018 Jul; 546(1-2):115-124. PubMed ID: 29729405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
    Ilekis JV; Tsilou E; Fisher S; Abrahams VM; Soares MJ; Cross JC; Zamudio S; Illsley NP; Myatt L; Colvis C; Costantine MM; Haas DM; Sadovsky Y; Weiner C; Rytting E; Bidwell G
    Am J Obstet Gynecol; 2016 Jul; 215(1 Suppl):S1-S46. PubMed ID: 26972897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered placental structure induced by maternal food restriction in guinea pigs: a role for circulating IGF-II and IGFBP-2 in the mother?
    Roberts CT; Sohlstrom A; Kind KL; Grant PA; Earl RA; Robinson JS; Khong TY; Owens PC; Owens JA
    Placenta; 2001 Apr; 22 Suppl A():S77-82. PubMed ID: 11312635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle mediated increased insulin-like growth factor 1 expression enhances human placenta syncytium function.
    Wilson RL; Owens K; Sumser EK; Fry MV; Stephens KK; Chuecos M; Carrillo M; Schlabritz-Loutsevitch N; Jones HN
    Placenta; 2020 Apr; 93():1-7. PubMed ID: 32090963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placenta-targeted Treatment Strategies for Preeclampsia and Fetal Growth Restriction: An Opportunity and Major Challenge.
    Cui J; Yang Z; Ma R; He W; Tao H; Li Y; Zhao Y
    Stem Cell Rev Rep; 2024 Aug; 20(6):1501-1511. PubMed ID: 38814409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticulate drug delivery in pregnancy: placental passage and fetal exposure.
    Menezes V; Malek A; Keelan JA
    Curr Pharm Biotechnol; 2011 May; 12(5):731-42. PubMed ID: 21342124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of adaptation of maternofetal transport of glutamine relative to placental size in normal mice, and in those with fetal growth restriction.
    McIntyre KR; Hayward CE; Sibley CP; Greenwood SL; Dilworth MR
    J Physiol; 2019 Oct; 597(19):4975-4990. PubMed ID: 31400764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.
    Han VK; Bassett N; Walton J; Challis JR
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental-specific IGF-II is a major modulator of placental and fetal growth.
    Constância M; Hemberger M; Hughes J; Dean W; Ferguson-Smith A; Fundele R; Stewart F; Kelsey G; Fowden A; Sibley C; Reik W
    Nature; 2002 Jun; 417(6892):945-8. PubMed ID: 12087403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental Drug Delivery to Treat Pre-Eclampsia and Fetal Growth Restriction.
    Deepak V; El-Balawi L; Harris LK
    Small; 2024 Oct; 20(41):e2311165. PubMed ID: 38745536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.